Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
Sponsor: Dharmais National Cancer Center Hospital
Summary
This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.
Official title: Effectiveness of Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
136
Start Date
2024-03-18
Completion Date
2028-03-21
Last Updated
2025-11-18
Healthy Volunteers
No
Conditions
Interventions
Lymphovenous bypass (LVB)
The Lymphovenous Bypass (LVB) procedure in this study is a microsurgical supermicrosurgery-based intervention specifically designed for the secondary prevention of breast cancer-related lymphedema following axillary lymph node dissection.
Locations (1)
Dharmais National Cancer Center
Jakarta, Jakarta Special Capital Region, Indonesia